XHKG
1526
Market cap174mUSD
Oct 09, Last price
0.90HKD
1D
4.05%
1Q
-25.62%
Jan 2017
-54.08%
IPO
-60.70%
Name
Rici Healthcare Holdings Ltd
Chart & performance
P/E
3.97
P/S
0.44
EPS
0.19
Div yield, %
5.20%
Shrs. gr., 5y
—
Rev. gr., 5y
7.75%
Revenues
2.80b
-4.41%
Net income
307m
+3.30%
CFO
719m
-9.00%
Dividend
Jun 24, 20260.02 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examination centers. By the close of 2021, specifically December 31st, the company's network included 68 medical examination centers. Beyond these core activities, Rici Healthcare also offers health advisory services, nursing care, diagnostic testing, and leasing arrangements. The firm was established in 2000 and has its principal corporate office located in Shanghai, China.
Key people
Lin Zhao
Vice President · since 2018
Haoze Fang
Executive Vice President, Executive Director, General Manager - Medical Examination Business Department · since 2020
Xiaoying Lin
Chief Operating Officer, Vice President, Executive Director, General Manager - Human Resources Center, Director of President Office · since 2019
Yixin Fang
Executive Chairman of the Board, Chief Executive Officer · since 2019
Hong Mei
Executive Director · since 2014
Kun Chen
Company Secretary · since 2020
Peixing Jiang
Non-Executive Independent Director · since 2017
Wenguo Tian
Independent Non-Executive Director · since 2025
Non-Executive Independent Director · since 2016
IPO date
Oct 06, 2016
Employees
8,976
Domiciled in
CN
Incorporated in
KY
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||